Stocklytics Platform
Asset logo for symbol ORGO
Organogenesis Holdings
ORGO61
$4.05arrow_drop_up0.49%$0.02
Penny Stock
Asset logo for symbol ORGO
ORGO61

$4.05

arrow_drop_up0.49%

Performance History

Chart placeholder
Key Stats
Open$4.08
Prev. Close$4.02
EPS-0.05
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$536.93M
PE Ratio-
LOWHIGH
Day Range3.93
4.20
52 Week Range1.96
4.70
Ratios
EPS-0.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Organogenesis Holdings (ORGO)

Organogenesis Holdings Inc (ORGO) is a leading regenerative medicine company that specializes in the development and commercialization of advanced wound care and surgical biologics. The company's innovative products are designed to promote the body's natural healing process and enhance patient outcomes. With a strong focus on research and development, Organogenesis is at the forefront of advancements in the field of regenerative medicine.
As of the latest stock price history, ORGO has shown promising growth and resilience in the market. The company has weathered economic uncertainties and has consistently delivered positive results. The stock has demonstrated strong performance and has gained significant traction among investors. ORGO's stock price has witnessed notable fluctuations, but the overall trend has been positive.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Gary S. Gillheeney Sr.
Headquarters
Canton
Employees
1030
Exchange
NASDAQ
add Organogenesis Holdings  to watchlist

Keep an eye on Organogenesis Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Organogenesis Holdings 's (ORGO) price per share?

The current price per share for Organogenesis Holdings (ORGO) is $4.05. The stock has seen a price change of $0.02 recently, indicating a 0.5% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Organogenesis Holdings (ORGO)?

For Organogenesis Holdings (ORGO), the 52-week high is $4.7, which is 16.17% from the current price. The 52-week low is $1.96, the current price is 106.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Organogenesis Holdings (ORGO) a growth stock?

Organogenesis Holdings (ORGO) has shown an average price growth of -3.66% over the past three years. It has received a score of 34 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Organogenesis Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Organogenesis Holdings (ORGO) stock price performance year to date (YTD)?

As of the latest data, Organogenesis Holdings (ORGO) has a year-to-date price change of -0.74%. Over the past month, the stock has experienced a price change of 40.14%. Over the last three months, the change has been 38.23%. Over the past six months, the figure is 50.56%. Looking at a longer horizon, the five-year price change stands at -19.48%.
help

Is Organogenesis Holdings (ORGO) a profitable company?

Organogenesis Holdings (ORGO) has a net income of $4.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 71.52% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.42% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $433.14M, although specific revenue growth data is currently not available. The gross profit is $309.79M. Operating income is noted at $12.52M. Furthermore, the EBITDA is $34.92M.
help

What is the market capitalization of Organogenesis Holdings (ORGO)?

Organogenesis Holdings (ORGO) has a market capitalization of $536.93M. The average daily trading volume is 4.08, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level